Related Experiment Video

Updated: Oct 9, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression

M Suganuma1, E Sueoka, N Sueoka

  • 1Saitama Cancer Center Research Institute, Japan.

Biofactors (Oxford, England)
|March 10, 2001
PubMed

Insights

Green tea extract, particularly EGCG, inhibits tumor necrosis factor-alpha (TNF-alpha) production, a key factor in tumor promotion. This suggests green tea

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Tea polyphenols possess various biological activities.
  • Tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in tumor promotion.
  • TNF-alpha-deficient mice studies highlight its essential role.

Purpose of the Study:

  • To investigate the inhibitory effects of green tea polyphenols, specifically EGCG, on TNF-alpha expression and release.
  • To determine the role of EGCG in modulating AP-1 and NF-kappaB activation.
  • To evaluate the cancer-preventive efficacy of green tea extract in vivo.

Main Methods:

  • Treatment of BALB/3T3 cells with okadaic acid and EGCG.
  • Analysis of AP-1 and NF-kappaB activation.
  • Administration of green tea extract to TNF-alpha transgenic mice.
  • Measurement of TNF-alpha, IL-1beta, and IL-10 gene and protein expression in lung tissue.
  • Assessment of synergistic effects with tamoxifen and sulindac.

Main Results:

  • EGCG dose-dependently inhibited AP-1 and NF-kappaB activation, leading to reduced TNF-alpha gene expression.
  • Green tea extract administration significantly reduced TNF-alpha gene and protein levels in the lungs of transgenic mice.
  • Green tea extract also inhibited the expression of IL-1beta and IL-10, cytokines induced by TNF-alpha.
  • Synergistic cancer-preventive effects were observed between EGCG and agents like tamoxifen and sulindac.

Conclusions:

  • Green tea polyphenols, particularly EGCG, effectively inhibit TNF-alpha, a critical factor in tumor promotion.
  • Green tea extract demonstrates efficacy in reducing TNF-alpha and associated cytokine expression in vivo.
  • Green tea shows promise as a non-toxic, efficacious cancer preventive agent for humans.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...